Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
astrazeneca
3
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
alzheimer's disease
cancer
clinical trials
cystic fibrosis
drugs
eli lilly
fda
merck
osteoarthritis
pfizer
stanford university
What
week
3
×
bio
drug
roundup
way
acquisitions
alzheimer’s
annual
assessed
attention
biggest
biotech
biotechs
build
buy
ceo
chose
close
communities
company
company’s
conference
daniel
debut
device
dyne’s
esmo
europe
firms
germany
gilead
hosted
investment
ipo
ipos
life
make
medical
microbiome
moves
Language
unset
Current search:
astrazeneca
×
week
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
